Sequent Scientific [SEQUENT] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sequent Scientific wins in 5 metrics, Divi's Laboratories wins in 14 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSequent ScientificDivi's LaboratoriesBetter
P/E Ratio (TTM)166.3365.37Divi's Laboratories
Price-to-Book Ratio6.6110.13Sequent Scientific
Debt-to-Equity Ratio62.470.03Divi's Laboratories
PEG Ratio1.402.47Sequent Scientific
EV/EBITDA30.6348.31Sequent Scientific
Profit Margin (TTM)1.85%23.89%Divi's Laboratories
Operating Margin (TTM)7.56%25.60%Divi's Laboratories
EBITDA Margin (TTM)7.56%25.60%Divi's Laboratories
Return on Equity2.84%14.64%Divi's Laboratories
Return on Assets (TTM)1.37%12.94%Divi's Laboratories
Free Cash Flow (TTM)$442.73M$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return-10.14%8.12%Divi's Laboratories
Price-to-Sales Ratio (TTM)3.0015.71Sequent Scientific
Enterprise Value$50.87B$1,480.60BDivi's Laboratories
EV/Revenue Ratio3.1715.34Sequent Scientific
Gross Profit Margin (TTM)46.86%60.33%Divi's Laboratories
Revenue per Share (TTM)$64$363Divi's Laboratories
Earnings per Share (Diluted)$1.12$87.36Divi's Laboratories
Beta (Stock Volatility)0.910.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Sequent Scientific vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sequent Scientific1.15%-8.42%9.29%-3.35%37.17%0.89%
Divi's Laboratories2.73%3.10%-4.83%-14.69%1.79%-3.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sequent Scientific-10.14%69.59%19.72%26.36%26.36%26.36%
Divi's Laboratories8.12%57.02%83.89%435.51%1,516.65%7,132.15%

News Based Sentiment: Sequent Scientific vs Divi's Laboratories

Sequent Scientific

News based Sentiment: POSITIVE

Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.

View Sequent Scientific News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Divi's Laboratories, with stellar FY25 results overshadowed by a weaker Q1 FY26 performance and fluctuating analyst opinions. The Nifty 50 exclusion adds another layer of complexity, creating a dynamic investment scenario that requires careful monitoring.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Sequent Scientific vs Divi's Laboratories

MetricSEQUENTDIVISLAB
Market Information
Market Cap i₹48.13B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,494,055437,716
90 Day Avg. Volume i754,164381,180
Last Close₹186.29₹5,866.00
52 Week Range₹117.35 - ₹240.70₹4,955.00 - ₹7,071.50
% from 52W High-22.60%-17.05%
All-Time High₹336.50 (Jun 28, 2021)₹7,071.50 (Jul 08, 2025)
% from All-Time High-44.64%-17.05%
Growth Metrics
Quarterly Revenue Growth0.13%0.14%
Quarterly Earnings Growth1.20%0.27%
Financial Health
Profit Margin (TTM) i0.02%0.24%
Operating Margin (TTM) i0.08%0.26%
Return on Equity (TTM) i0.03%0.15%
Debt to Equity (MRQ) i62.470.03
Cash & Liquidity
Book Value per Share (MRQ)₹28.19₹563.87
Cash per Share (MRQ)₹2.52₹132.86
Operating Cash Flow (TTM) i₹360.47M₹19.67B
Levered Free Cash Flow (TTM) i₹218.78M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Sequent Scientific vs Divi's Laboratories

MetricSEQUENTDIVISLAB
Price Ratios
P/E Ratio (TTM) i166.3365.37
Forward P/E i36.89101.43
PEG Ratio i1.402.47
Price to Sales (TTM) i3.0015.71
Price to Book (MRQ) i6.6110.13
Market Capitalization
Market Capitalization i₹48.13B₹1.61T
Enterprise Value i₹50.87B₹1.48T
Enterprise Value Metrics
Enterprise to Revenue i3.1715.34
Enterprise to EBITDA i30.6348.31
Risk & Other Metrics
Beta i0.910.18
Book Value per Share (MRQ) i₹28.19₹563.87

Financial Statements Comparison: Sequent Scientific vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SEQUENTDIVISLAB
Revenue/Sales i₹4.41B₹24.10B
Cost of Goods Sold i₹2.35B₹9.56B
Gross Profit i₹2.07B₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹333.50M₹6.17B
EBITDA i₹505.30M₹8.48B
Pre-Tax Income i₹255.20M₹7.33B
Income Tax i₹79.50M₹1.88B
Net Income (Profit) i₹175.70M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SEQUENTDIVISLAB
Cash & Equivalents i₹626.60M₹4.15B
Total Current Assets i₹8.74B₹100.81B
Total Current Liabilities i₹5.05B₹14.52B
Long-Term Debt i₹3.00B₹20.00M
Total Shareholders Equity i₹7.70B₹149.69B
Retained Earnings i₹1.25B₹134.00B
Property, Plant & Equipment i₹2.84B₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SEQUENTDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSEQUENTDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,494,055437,716
Average Daily Volume (90 Day) i754,164381,180
Shares Outstanding i249.89M265.47M
Float Shares i118.88M120.77M
% Held by Insiders i0.52%0.52%
% Held by Institutions i0.13%0.29%

Dividend Analysis & Yield Comparison: Sequent Scientific vs Divi's Laboratories

MetricSEQUENTDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.00₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends i₹0.00₹150.00
Ex-Dividend DateN/AJul 25, 2025